Themes
Business
Talent
At the park
Communities
Jobs & internships
Events
News
Contact
Why settle for average when you can shape the future of health in one of Europe’s top life sciences ecosystems? The 2025 Entrepreneurial Ecosystem Index confirms it: the Agglomeration Leiden–Bollenstreek now ranks #3 in the Netherlands, surpassing Brainport and closing in on Amsterdam. That’s a sign of long-term momentum for our region.
Because of consistent investment in what matters:
It isn’t a one-year spike either, but a structural improvement that reflects how public institutions and private companies have collaborated to create an environment where life sciences can thrive.
If you’re growing a biotech, medtech, or pharmaceutical business in Europe, Leiden is one of the few places where research, business, and regulation are within walking distance. It’s where new ideas become therapies. Where regional collaboration is the norm. And where growth is matched with talent. The data backs it up. Now is the time to be part of it.
Credits to the authors Utrecht University (Erik Stam) and Birch Consultants’ authors (Tom Hendricksen, Jan Peter van den Toren, Bram Schoenmakers)
Here’s the full report and what’s your takeaway?
Marieke Vinkenoog and Simon Christian Hansmann have been awarded the Krijn Rietveld Memorial Innovation Awards for their research in blood donation and colorectal cancer. Vinkenoog’s work on predictive modeling for donor eligibility and Hansmann’s identification of cancer cells linked to tumor recurrence exemplify the integration of advanced scientific methods to address pressing health challenges.
OEGSTGEEST, the Netherlands, September 04, 2025 / Biotech Newswire / -- Toxys, a leading innovator in animal-free toxicology solutions, announces that its flagship...
This October, YES!Delft launches its MedTech Accelerator: a programme designed to help start-ups in the medical technology sector take their innovation to the next stage. The...